Multiple Digital Biomarkers for Optimization of IBD Care

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

September 8, 2025

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Crohn Disease (CD)Ulcerative Colitis (UC)Inflammatory Bowel Disease (IBD)
Interventions
DEVICE

monitoring of wearable data, shopping data, biomarkers and patient reported outcomes

"1. All participants will receive a wearable device type Corsano Health Cardio watch 287-2 which is provided by the sponsor via Inovigate. Participants will be encouraged to wear the device 24h per day and need to wear the wearable device at least 12 hours per day, preferential during daytime.~2. All participants will receive a loyalty card (Xtra card Colruyt group) which is provided by the sponsor via Inovigate for food data capturing. The patient is requested to execute all grocery shopping at one of the Colruyt Group stores. He/she will always need to offer the loyalty card to the cashier prior to payment. The purchase receipt will then be automatically sent to the central food data repository at the sponsor set up for this study. Non-food or non-food related data will neither be captured nor stored during the trial.~3. biomarkers in blood and feaces will be monitored according to standard of care~4. patient reported outcomes will be monitored according to standard of care"

Trial Locations (1)

2820

Imelda General Hospital, Bonheiden

All Listed Sponsors
collaborator

Agentschap Innoveren & Ondernemen (VLAIO)

UNKNOWN

lead

Imelda GI Clinical Research Center

OTHER